Jiangsu Hengrui Medicine
600276.SS
#522
Rank
S$60.13 B
Marketcap
S$9.06
Share price
-0.04%
Change (1 day)
-19.86%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2026 (TTM): S$0.19

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is S$0.19. In 2025 the company made an earnings per share (EPS) of S$0.22 an increase over its 2024 EPS that were of S$0.18.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$0.19-11.2%
2025S$0.2224.14%
2024S$0.1842.43%
2023S$0.128.77%
2022S$0.11-20.62%
2021S$0.14-26.59%
2020S$0.2027.24%
2019S$0.1528.41%
2018S$0.1220.04%
2017S$0.0998431.21%
2016S$0.0760911.46%
2015S$0.0682736.27%
2014S$0.0501019.77%
2013S$0.0418318.05%
2012S$0.0354323.9%
2011S$0.0286026.9%
2010S$0.0225312.37%
2009S$0.0200656.6%
2008S$0.012819.18%
2007S$0.01173114.48%
2006S$0.00546964.83%
2005S$0.00331835.55%
2004S$0.00244829.73%
2003S$0.00188719.86%
2002S$0.001574-2.71%
2001S$0.0016181.02%
2000S$0.001602